Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01580930 · ClinicalTrials.gov registry record · NA
Changes in Habitual Physical Activity and Inactivity
A NA study, sponsored by University of Massachusetts, Amherst.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT01580930: Completed NA study, sponsored by University of Massachusetts, Amherst.
NCT01580930 is a NA study that has completed, run by University of Massachusetts, Amherst. The registered enrollment target is 57 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01580930, a NA study, has completed, sponsored by University of Massachusetts, Amherst.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if individuals involved in exercise training change habitual activity and inactivity behavior outside of exercise training. Eligible participants were randomly assigned to one of four groups: control, exercise training, sedentary time reduction, or exercise training plus sedentary time reduction. It was hypothesized that participants in the exercise training group will compensate for exercise training by reducing free-living physical activity behavior and increasing sedentary time. Participant free-living behavior was monitored for one week at baseline, 3, 6, 9 and 12 weeks using an activPAL wearable monitor.
Primary Outcome
Measure is based on data collected with a wearable monitor that assesses time spent sitting/lying, standing, and walking
Interventions
- BEHAVIORAL exercise training
- BEHAVIORAL sedentary time reduction
- BEHAVIORAL exercsie training plus sedentary time reduction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2010-03 |
| Est. Completion | 2011-05 |
| Phase | NA |
What the finished NCT01580930 record still lists
NCT01580930 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which exercise training is the first listed.
NCT01580930 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01580930 about?
NCT01580930 is a clinical study titled "Changes in Habitual Physical Activity and Inactivity". The purpose of this study is to determine if individuals involved in exercise training change habitual activity and inactivity behavior outside of exercise training. Eligible participants were randomly assigned to one of four groups: control, exercise training, sedentary time reduction, or exercise ...
What is the current status of trial NCT01580930?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2010-03. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01580930?
The interventions under investigation include: exercise training (BEHAVIORAL), sedentary time reduction (BEHAVIORAL), exercsie training plus sedentary time reduction (BEHAVIORAL).
Who is sponsoring clinical trial NCT01580930?
This trial is sponsored by University of Massachusetts, Amherst, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01580930's enrollment target sits among peer trials
57 1261st of 2000 higher than 739 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia